Gastrointestinal tumour

1. Rapamycin lowers the risk of gastrointestinal tumour in mice.

   “delay in, but not full blockade of, the development of a range of proliferative lesions, including gastro-intestinal and thyroid tumours”

   Animalsheterozygous germline Pten lossgastrointestinal tractlow dose

   Long-term treatment of cancer-prone germline PTEN mutant mice with low-dose rapamycin extends lifespan and delays tumour development

   The Journal of pathology·31 Oct 2022

More on Rapamycin